Rein Therapeutics Inc. RNTX
0.75
0.01
1.35%
as of 25 Sep
- Market cap
- $73.8M
- P/E
- 0.0×
Follow RNTX
Insider Buys
alert about insiders buying in the last 12 month
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Current Ratio |
5.18 | 10.60 | 4.05 | 3.35 | 4.12 | 10.69 | 6.46 | 4.17 | 2.38 | 0.70 |
Net Debt/EBITDA |
1.16 | 2.21 | 0.48 | 0.44 | 0.69 | 1.75 | 0.77 | 1.08 | 0.46 | 0.15 |
Debt/Assets |
0.00% | 0.00% | 17.62% | 19.01% | 2.37% | 0.33% | 0.15% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.27 | 0.31 | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.83 | 0.91 | 0.89 | 0.90 | 0.97 | 0.91 | 0.91 | 1.26 | 0.35 | 0.39 |
Capex/Depreciation |
0.00 | 6.17 | 126.37 | 1.99 | 1.32 | (0.25) | 0.00 | 0.28 | 0.00 | 0.00 |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 56.86% | 70.76% | (93.62%) | (164.77%) | (150.00%) | (93.33%) | (87.42%) | (123.34%) | (772.80%) | 533.38% | |
| (165.28%) | (60.62%) | (76.02%) | (103.44%) | (98.83%) | (80.73%) | (77.54%) | (24.58%) | (74.77%) | (115.51%) | |
ROIC |
0.00% | 0.00% | (472.26%) | (674.20%) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(106.37%) | (48.08%) | (133.14%) | (209.69%) | (170.88%) | (59.74%) | (147.25%) | (113.18%) | (795.08%) | 2,689.91% |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.81 | 0.78 | 0.82 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Free Cash Flow per Share |
(698.33) | (55.54) | (43.90) | (21.70) | (11.63) | (5.37) | (5.48) | (4.30) | (1.24) | (0.76) |
Cash per Share |
964.65 | 136.59 | 28.12 | 14.92 | 8.26 | 10.35 | 4.69 | 3.77 | 0.72 | 0.13 |
Shareholders Equity per Share |
(5,200.28) | 128.42 | 26.60 | 13.08 | 6.98 | 9.89 | 4.10 | 1.50 | 0.52 | (1.10) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(5,200.28) | 128.42 | 26.60 | 13.08 | 6.98 | 9.89 | 4.10 | 1.50 | 0.52 | (1.10) |
Free Cash Flow |
(15.01) | (20.67) | (32.35) | (26.62) | (20.27) | (23.84) | (24.86) | (19.77) | (22.29) | (19.36) |
Working Capital |
17.00 | 46.95 | 16.41 | 13.71 | 12.37 | 43.67 | 18.49 | 13.88 | 7.91 | (1.85) |
Capital Expenditures |
— | (0.14) | (4.42) | (0.15) | 0.20 | (0.09) | — | 0.04 | — | — |
Net Current Asset Value |
(112.75) | 46.95 | 11.06 | 9.13 | 12.15 | 43.60 | 18.49 | (80.85) | (39.15) | (47.92) |
| Other line items | ||||||||||
Quick Ratio |
5.09 | 10.39 | 3.86 | 3.13 | 3.64 | 10.19 | 6.28 | 3.95 | 2.24 | 0.52 |
Depreciation/Fixed assets |
2.17 | (0.15) | 0.00 | (0.26) | 10.27 | 2.82 | (0.56) | 7.95 | 37,063.00 | 0.00 |
Cash ROIC |
16.60% | (20.97%) | (77.12%) | (67.97%) | (76.04%) | (26.53%) | (62.46%) | (81.85%) | (100.18%) | 77.84% |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(698.33) | (55.16) | (37.90) | (21.58) | (11.74) | (5.35) | (5.48) | (4.31) | (1.24) | (0.76) |
Capex per Share |
0.00 | (0.38) | (6.00) | (0.12) | 0.12 | (0.02) | 0.00 | 0.01 | 0.00 | 0.00 |
Average Payables |
1.79 | 1.79 | 1.67 | 1.59 | 1.52 | 1.40 | 1.47 | 1.46 | 1.05 | 2.44 |
Average Assets |
11.01 | 37.35 | 41.50 | 28.39 | 21.41 | 32.41 | 35.24 | 64.01 | 84.10 | 43.17 |
Average Common Equity |
(32.00) | (32.00) | 33.70 | 17.82 | 14.11 | 28.03 | 31.26 | 12.76 | 8.14 | (9.35) |
Capex to Sales |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | — | — |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates